when should i take my semaglutide injection Best Time to Semaglutide: Timing Guide for Optimal Results Semaglutide Tips & Aftercare |
Description
In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)
#GLP-1 #Semaglutide #Tirzepatide #weightloss #diabetes
Favorece el equilibrio metablico y la sensibilidad a la insulina
If you're on medication or have a medical condition, consult your healthcare provider before use
Semaglutide is a type of Peptide
Objectives This study aimed to compare weight loss outcomes between patients receiving semaglutide and those undergoing revisional metabolic and bariatric surgery (RMBS) due to RWG
